FDA approves perioperative bladder cancer treatment
FDA approves Keytruda (pembrolizumab) and (pembrolizumab and berahyaluronidase alfa-pmph), each with (enfortumab vedotin-ejfv), as treatment before and after surgery for adults with muscle-invasive bladder cancer (MIBC).
MRK•
